Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Darwin Biotech is a Chinese regenerative medicine company specializing in the development of exosome-based therapeutics and stem cell technologies. The company focuses on addressing unmet needs in dermatology and tissue repair, particularly targeting androgenetic alopecia and skin rejuvenation. Their proprietary platform enables the large-scale production and standardization of high-purity extracellular vesicles derived from mesenchymal stem cells. Beijing Darwin Biotech integrates clinical research with aesthetic medicine to provide non-invasive regenerative solutions. The firm is recognized for its 'Darwin 1' series of products aimed at hair follicle restoration and anti-aging applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Darwin Biotech.